Effects of Concomitant Fluvoxamine on the Plasma Concentration of Etizolam in Japanese Psychiatric Patients: Wide Interindividual Variation in the Drug Interaction

@article{Suzuki2004EffectsOC,
  title={Effects of Concomitant Fluvoxamine on the Plasma Concentration of Etizolam in Japanese Psychiatric Patients: Wide Interindividual Variation in the Drug Interaction},
  author={Yutaro Suzuki and Yoshiaki Kawashima and Toshiki Shioiri and Toshiyuki Someya},
  journal={Therapeutic Drug Monitoring},
  year={2004},
  volume={26},
  pages={638-642}
}
Administration of fluvoxamine with concomitant benzodiazepines is common in clinical situations. This study investigated the effects of the coadministration of fluvoxamine on plasma concentrations of etizolam and evaluated the effects of various fluvoxamine doses on drug interactions with etizolam. Subjects were 18 Japanese outpatients concomitantly treated with fluvoxamine before or after monotherapy with etizolam. Plasma concentrations of etizolam were measured using a column-switching high… Expand
Femoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases
TLDR
In all of the cases, multiple drugs were detected, with the most common being pregabalin followed by morphine/heroin, diazepam, and benzoylecgonine, illustrating the increasing problem of poly-substance use in drug abusers. Expand
Understanding the pharmacokinetics of anxiolytic drugs
TLDR
A need for a more balanced assessment of the benefits and risks associated with benzodiazepine use, particularly considering pharmacokinetic profile of the drugs to ensure that patients, who would truly benefit from these agents, are not denied appropriate treatment. Expand
Pharmacokinetic interactions of selective serotonin reuptake inhibitors with other commonly prescribed drugs in the era of pharmacogenomics
TLDR
The significance of drug interactions in the era of pharmacogenomics is discussed to underline the need for using information on both genotype and drug interactions towards implementing better clinical outcomes through personalized medicine. Expand
Determination of fluvoxamine in rat plasma by HPLC with pre-column derivatization and fluorescence detection using 4-fluoro-7-nitro-2,1,3-benzoxadiazole.
TLDR
Results indicate that the method presented is useful to determine the FLU levels in rat plasma of volumes as small as 100 microL and can be applied to pharmacokinetic studies. Expand
Case report: Etizolam and its major metabolites in two unnatural death cases.
TLDR
This method was applied to two unnatural death cases suspected to involve etizolam and its two metabolites were detected in these cases and is satisfactory for clinical and forensic purposes. Expand
Evaluation of inhibitory drug interactions during drug development: Genetic polymorphisms must be considered
g g s T e p a T i p l s The evaluation of drug interactions during the drug evelopment process is an important requirement that rovides information for the product label and medical eferences.Expand
High-Throughput Radiometric CYP2C19 Inhibition Assay Using Tritiated (S)-Mephenytoin
TLDR
This assay represents a non-HPLC, high-throughput version of the classic (S)-mephenytoin 4′-hydroxylation assay, which is the most widely used method to assess the potential for CYP2C19 inhibition of new chemical entities. Expand
Current awareness: Pharmacoepidemiology and drug safety
  • 2005
In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliographyExpand

References

SHOWING 1-10 OF 13 REFERENCES
Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles
TLDR
Coadministration of FLV significantly increased the plasma concentrations of ALP compared with ALP monotherapy, and wide variations were observed in the drug interactions, with the CYP2C19 genotype possibly being related to these interactions. Expand
A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine
TLDR
The pharmacokinetic and pharmacodynamic interaction between fluvoxamine, a serotonin reuptake inhibitor, and alprazolam, a triazolobenzodiazepine, is assesed and the dosage of alpazolam should be reduced during co-administration with fluVoxamine. Expand
Inhibition of diazepam metabolism by fluvoxamine: A pharmacokinetic study in normal volunteers
TLDR
Fluvoxamine inhibits the biotransformation of diazepam and its active N‐demethylated metabolite, and the magnitude of this interaction is likely to have considerable clinical significance. Expand
Single and multiple dose pharmacokinetics of etizolam in healthy subjects
TLDR
Based on the kinetic characteristics of the parent drug and its metabolite, etizolam can be regarded as a short-acting benzodiazepine, with elimination kinetics between those of short-intermediate derivatives and ultra-rapidly eliminated Benzodiazepines. Expand
Importance of the Cytochrome P450 2D6 Genotype for the Drug Metabolic Interaction Between Chlorpromazine and Haloperidol
TLDR
There were marked interindividual variations in the interactive effects of chlorpromazine, and the importance of five CYP2D6 genotypes on the percentage of change in plasma concentrations of haloperidol and reduced haloperIDol was analyzed. Expand
Dose-response evaluation of the interaction between sertraline and alprazolam in vivo.
TLDR
It is suggested that sertraline (50-150 mg/day) does not alter the single-dose kinetics or dynamics of alprazolam; therefore, the combination may be prescribed without an increased risk ofAlprazoam toxicity. Expand
Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
In vitro preparations of human liver microsomes were used to study the inhibiting effects of two selective serotonin reuptake inhibitor (SSRI) antidepressants, paroxetine and fluvoxamine, onExpand
Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine.
TLDR
Ketoconazole was a potent inhibitor of ALP metabolism in vitro, suggesting that ALP hydroxylation is mediated by the cytochrome P450-3A sub-family, and fluoxetine and sertraline were weak inhibitors. Expand
Drug interactions with newer antidepressants: role of human cytochromes P450.
TLDR
This review evaluates the clinical implications of the metabolic profiles of the newer antidepressants, the relative activities of various new antidepressants as inhibitors of human cytochrome P450, and the various in vivo and in vitro methodologies that can be used for identification and quantification of drug interactions. Expand
Drug interactions--friend or foe?
TLDR
A better understanding of the cytochrome P450 system is provided with a focus on those enzymes most involved in drug metabolism, and emphasis is placed on antidepressant medications, how they are metabolized by the P 450 system, and how they alter the metabolism of other drugs. Expand
...
1
2
...